about
Immunopathology of the lung: a reviewBiological effects of short-term, high-concentration exposure to methyl isocyanate. VI. In vitro and in vivo complement activation studies.Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis.Demonstration of inflammatory mediator-induced inflammation and endothelial cell damage in the anterior segment of the eye.Lactoferrin Is an Allosteric Enhancer of the Proteolytic Activity of Cathepsin G.Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cellsIn vitro and in vivo production of chemotactic inhibitors by tumor cells.Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonizationHuman neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factorsExpression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragmentsAlveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases.Acute inflammatory pulmonary reactions induced by chemotactic factors.Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxideThe role of elastases in the development of emphysema.
P2860
Q28397007-61495E93-71C3-4589-B077-9EFB463AF577Q34661020-EC52A478-0A50-4564-9206-5A908C25AB9EQ35885272-09EAF160-A5D9-4934-8DF6-E8FD2FA75E21Q35885280-BA3E1296-4F94-48DF-84E5-9D02A1D9E967Q35961015-96F3AFB3-9B0B-4CF0-86A3-8876A97091A5Q36092712-187203A4-D7E7-4A58-B020-95F228303EB1Q36092770-71F6CCC5-E346-4F52-834A-CFC1E3163EA5Q36218690-EFF53FE6-24A1-4E84-BB7E-819BA2F89F78Q36341947-F3501FB9-C090-43BE-BD74-CB8A4D1DCE50Q36347899-4995A6F0-81DC-45F9-8643-1EFD41F2DF90Q37019905-E7AA3440-4055-4792-BA72-0141E24E41EAQ37035106-908B3CA3-3AA5-46AD-A147-1B217C03C690Q37035971-EF6C45B6-85B8-4592-BCDC-0BF24B347D32Q37039731-D96EEBA0-56BC-455A-955D-45A2A485240DQ37042134-BBEFB9E0-6677-428F-A2D4-F3150832F56CQ40231973-D9FDE929-2B65-497B-B896-A6AED72069F3Q40975524-58981027-572B-4F70-96D9-6F471ADA7E7AQ41719277-1257C594-47FE-4BD4-9B71-E411B2CB751BQ42051133-49AB04CA-C13D-48C1-A0CE-4D43F2F68D38Q54662390-A660FBE6-5E7A-41FF-8AA0-1E5B1F94898B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1977
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotactic factor inactivators of human granulocytes
@en
Chemotactic factor inactivators of human granulocytes.
@nl
type
label
Chemotactic factor inactivators of human granulocytes
@en
Chemotactic factor inactivators of human granulocytes.
@nl
prefLabel
Chemotactic factor inactivators of human granulocytes
@en
Chemotactic factor inactivators of human granulocytes.
@nl
P2093
P2860
P356
P1476
Chemotactic factor inactivators of human granulocytes
@en
P2093
P2860
P304
P356
10.1172/JCI108887
P407
P577
1977-12-01T00:00:00Z